Angela L Ambakhutwala

Title: Innovations by Angela L Ambakhutwala

Introduction

Angela L Ambakhutwala is an accomplished inventor based in Glen Allen, VA (US). She has made significant contributions to the field of immunotherapy and diagnostics, holding a total of 2 patents. Her work focuses on developing innovative solutions to enhance immune responses against diseases, particularly cancer.

Latest Patents

Ambakhutwala's latest patents include "Target peptides for immunotherapy and diagnostics" and "Isolated T cell receptors and methods of use therefor." The first patent presents a set of target peptides that are presented by various HLA molecules on the surface of disease cells. These peptides are designed to stimulate an immune response to proliferative diseases, function as immunotherapeutics, facilitate antibody recognition of tumor boundaries, act as biomarkers for early detection, and serve as targets for generating antibody-like molecules. The second patent provides isolated T cell receptors (TCRs) and TCR-like molecules that bind to phosphopeptide-HLA-A2 complexes, along with methods for their use in pharmaceutical compositions and kits.

Career Highlights

Throughout her career, Ambakhutwala has worked with prestigious institutions such as the University of Virginia and the University of Birmingham. Her research has contributed to advancements in immunotherapy, showcasing her dedication to improving patient outcomes through innovative medical solutions.

Collaborations

Some of her notable coworkers include Victor H Engelhard and Kara L Cummings. Their collaborative efforts have furthered the research and development of groundbreaking technologies in the field of immunology.

Conclusion

Angela L Ambakhutwala's contributions to immunotherapy and diagnostics highlight her role as a leading inventor in the medical field. Her innovative patents and collaborations reflect her commitment to advancing healthcare solutions.